Chemomapping of artichoke (cynara scolymus l.) and fenugreek (trigonella foenum-graecum l.) extracts, and analysis of generated biological effects using in vitro and in vivo modell systems by Vigh, Szabolcs
Theses of Doctoral (PhD) dissertation  
 
 
 
CHEMOMAPPING OF ARTICHOKE (CYNARA 
SCOLYMUS L.) AND FENUGREEK (TRIGONELLA 
FOENUM-GRAECUM L.) EXTRACTS, AND ANALYSIS OF 
GENERATED BIOLOGICAL EFFECTS USING IN VITRO 
AND IN VIVO MODELL SYSTEMS 
 
 
 
Szabolcs Vigh 
doctorand 
 
Supervisors: 
Dr. Endre Máthé 
associated professor 
Dr. Béla Kovács 
university professor 
 
 
 
UNIVERSITY OF DEBRECEN 
Jenő Hankóczy Doctoral School 
 
 
Debrecen, 2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
1. INTRODUCTION AND OBJECTIVES OF THE DISSERTATION 
In the 21st century, despite the huge progress of pharma industry, it becomes an 
evergrowing trend to turn our attention towards herbal plants and remedies to ease the 
preasure on the general health condition of humans across the planet.  Such medicinal 
plants and their bioactive constituents were of great inspiration for drug formulations, and 
recently they are widely used for nutraceuticals manufacturing, yet many times their 
pharmacological effects and mechanism of actions are not directly proved neither on 
individual nor on cellular levels. Many herbal remedies not being toxic are licensed for 
human consumption, but their dose-dependent effect remain largely unknown not talking 
about the individual consumers’ genomes and health statuses determined responses.  It 
has also demonstrated that the bioactive compounds administration in order to treat 
chronic diseases or their preventive utilization can induce health threatening effects too. 
Taken together all these considerations, it seems likely that the bioactive compounds 
preventive and/or therapeutic applications must pay attention to every single detail, and 
in the postgenomic era, a system biology type of approach would be the right choice to 
follow to fulfill the mentioned requirements.  
Several epidemiological studies are indicating that the advanced consumer lifestyle 
contributes substantially to death cases seen for patients with chronic diseases. Hungarian 
people general health condition does not excels as compared to other European contries, 
while on a world wide scale it is midway positioned (Tompa, 2011; WHO). In Hungarian 
terms, among middle and elderly individuals, the heart and coronary deseases are 
represented with a staggering 54%, cancer with 27%, gastro-intestinal diseases with 8% 
and respiratory system specific diseases share is 4% with respect to the death causes. It 
has been demonstrated that the heart and coronary diseases therapy and prevention 
efectiveness increased substantially during the last decades. The efficiency of cancer 
therapy is growing, though its prevention keep on failing despite the evergrowing efforts 
to carry out screens on national levels. In Hungary since 2013 the cancer deaths rate looks 
ruther constant, and the lung with colon cancers are the leading cancer types among both 
men and women. Breast and prostate cancers are on the third position, and unfortunately 
their prevention is far more unefficient as compared to lung and colon cancers. 
The causes of cancer are ruther complicated, and besides genetic susceptibility, the 
environmental factors like nutrition, reduced physical activity and stress are also playing 
influential roles. On the other hand a growing body of evidencies are suggesting that 
proper environmental interventions can increase the prevention and/or treatments success. 
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Actually we are not left with other options because the gene therapy is still struggling 
with identifying the proper intervention method in order to substitute the genetic 
susceptibility responsibele mutant alleles with their normal counterparts. 
Lately the application of bioactive compounds of plant origin has become a major 
imperative with respect to heart and coronary diseases and cancer treatment and/or 
prevention (Dietz et al., 2016). Identification and characterization of such bioactive 
compounds attracted much attention from the scientific community (American Cancer 
Society, 2016). To Youyou’s 2015 Nobel Prize for medicine is a great example of one 
such a plant derived compound. The artemisinin isolated from Artemisia annua could be 
used to efficeniently treat malaria. 
My research work is layed on the above mentioned scientific fondations. The 
artichoke (Cynara scolymus L.) and fenugreek (Trigonella foenum-graecum L.) based 
plant extracts production and chemical characterization with UHPLC-ESI-MS was 
follwed by the in vitro and in vivo analysis of their cytotoxic and genotoxic effects. The 
aim of my research was to identify and characterize novel plant derived extracts that show 
anti-tumor effects. 
During my work I have been looking for answers in relation with the following 
questions: 
1. What is the bioactive compound content of aqueous and hydro-alcoholic artichoke 
and fenugreek extracts? 
2. What kind of similarities and differencies exist between the bioactive compound 
profiele of artichoke and fenugreek extracts? 
3. What biological effects could be expected from the extracts based on their 
bioactive compound content? 
4. What is the total polyphenol, flavonoid and antocyanin content of extracts, and 
what in vitro antioxidant activity do they feature? 
5. How are going to affect the aqueous and hydro-alcoholic artichoke and fenugreek 
extracts the viability of T-47D and ZR-75-1 human breast cancerous cell lines?  
6. Are there going to affect the artichoke and fenugreek extracts the viability 
Drosophila melanogaster (fruitfly), and can it be proved their cytotoxic and/or 
genotoxic effect? 
7. Could it be predicted the human application of artichoke and fenugreek extracts 
based on their bioactive compound profile and the associated in vitro and in vivo 
effects? 
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2. MATERIALS AND METHODS 
2.1. Preparation of plant extracts 
The artichoke dried leaves were produced by the TTDR 2000 Ltd., Hungary. 10 g 
of sample was extracted for 5 min with 200 ml of boiling distilled water. It was allowed 
to cool to room temperature (RT), filtered and stored in refrigerator. Another 50 g of dried 
artichoke leaves were extracted twice with 500 ml aqueous 50% ethanol solution by 
stirring for 4 hrs on a magnetic stirrer. This extract was filtered, evaporated under vacuum 
and stored in refrigerator 
The fenugreek seeds were produced by TRIGONELLA MED. LTD., 
Mosonmagyaróvár, Hungary. Fenugreek seeds were dried at 40 °C and powdered. 15 g 
of the powder was extracted with 300 ml of boiling distilled water for 5 min. The mixture 
was allowed to cool at RT, filtered and stored in refrigerator. Other 15 g of powdered 
fenugreek seeds were refluxed on a magnetic stirrer with 300 ml aqueous 80% ethanol 
for 3 hrs. The mixture was filtered and the filtrate was concentrated by rotary evaporator 
and stored in refrigerator. 
2.2. UHPLC-ESI-MS analysis 
The UHPLC system (Dionex Ultimate 3000RS equipped with a Thermo Accucore 
C18 column, 100/2.1 with a particle size of 2.6 μm) was coupled to a Thermo Q Exactive 
Orbitrap mass spectrometer equipped with an electrospray ionization source (ESI). Eluent 
A (500 ml of water containing 10 ml of acetonitrile, 0.5 ml of formic acid and 2.5 mM of 
ammonium formate) and eluent B (500 ml of acetonitrile containing 10 ml of water, 0.5 
ml of formic acid and 2.5 mM of ammonium formate)  were used in the HPLC separation 
in positive ionization mode, and eluent A (500 ml of water containing 10 ml of acetonitrile 
and 2.5 mM of ammonium acetate) and eluent B (500 ml of acetonitrile containing 10 ml 
of water and 2.5 mM of ammonium acetate)  were used in the HPLC separation in 
negative ionization mode. Flow rate was 200 μl/min. The following gradient elution 
program was used both positive and negative ionization mode: 0-1 min, 95% A, 1-22 min, 
20% A; 22-24 min, 20% A; 24-26 min, 95% A; 26-40 min, 95% A. 5 μl of samples were 
injected in every run. The Q Exactive hybrid quadrupole-orbitrap mass spectrometer was 
operated with the following parameters: capillary temperature 320 °C, spray voltage 4.0 
kV in positive mode and 3.8 kV in negative mode, the resolution was set to 35000 in the 
case of MS and to 17500 in the case of MS/MS. The mass range scanned was 100-1000 
m/z. Collision energy was 40NCE in the MS/MS scans. 
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2.3. Spectrophotometric methods on the plant extracts 
2.3.1. Determination of total phenolic content 
Total phenolic content was determined using the method developed by Singleton 
and Rossi (1965). Total phenolic content was estimated by the Folin-Ciocalteu 
colorimetric method, using gallic acid as a standard phenolic compound. 200 µl of 
extracts were added to 3000 µl of distilled water, 500 µl of Folin-Ciocalteu reagent and 
2000 µl of sodium carbonate solution (15 g/100ml), and the mixture was allowed to stand 
for 20 min at RT. 4300 µl of distilled water was added and the absorbance was measured 
at 765 nm after 1 hour incubation period with the spectrophotometer (Perkin Elmer 
Lambda 35). The total flavonoid contents were calculated from a calibration curve with 
50, 100, 300, 500, 750 µg/ml points and the results were expressed as mg gallic acid 
equivalent per g dry weight. Each extract was measured in triplicate. 
2.3.2. Quantification of total flavonoids 
The total flavonoid content of the extract was determined by the aluminium chloride 
colorimetric method following the procedure described by Dae-Ok Kim et al. (2003). We 
have made a reagent solution containing 5 ml (10g/ml) of aluminium chloride, 5 ml of 
KOAc (potassium acetate, 1M), 75 ml of methanol and 140 ml of distilled water (AS). 
0.5 ml of the extract was mixed with 4.5 ml of AS, filtered (0.45 µm) and the absorbance 
was determined at 415 nm in the spectrophotometer (Perkin Elmer Lambda 35). The 
concentrations were calculated based on the equation obtained from the standard rutin 
curve (10, 40, 70, 100 µg/ml). Results were expressed as mg rutin equivalents. Each 
extract was measured in triplicate. 
2.3.3. Determination of total anthocyanins 
The total anthocyanin (TA) content was determined using an earlier described 
method (Lee et al., 2005). It detects the total monomeric anthocyanin concentration by 
the pH differential method. The method is a rapid and simple spectrophotometric 
application based on the anthocyanin structural transformation that occurs upon a change 
in pH (colored at pH1 and colorless at pH4). The standard solution was prepared by 
weighing 82.2 mg of cyanidin-3-glucoside chloride, dissolving in distilled water and 
diluting to a final volume of 1 L in a volumetric flask. 0.3 ml of extract was added to 2 
ml of buffer (pH=1 or pH=4) and 1.7 ml of distilled water. Samples were filtered (0.45 
µm), and absorbance recorded using a Perkin Elmer Lambda 35 spectrophotometer at 
wavelengths of 520 and 700 nm, for solutions at pH 1.0 and pH 4.5, respectively. Results 
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were expressed as cyanidin-3-glucoside (% w/w) equivalents. Total anthocyanin contents 
were calculated as follows: 
l
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where: A = (A520nm – A700nm)pH1 – (A520nm – A700nm)pH4; MW (molecular weight) = 449.2 
g/mol for cyanidin-3-glucoside; DF = dilution factor; l = path length in cm; ε = 26 900 
molar extinction coefficient, in L* mol–1 * cm–1 , for cyd-3-glu; and 103 = factor for 
conversion from g to mg. Each extract was measured in triplicate. 
2.3.4. Determination of antioxidant capacity by the DPPH method 
The DPPH (2,2- Diphenyl-1-picrylhydrazyl, Sigma-Aldrich) method was used to 
determine the antioxidant capacity of artichoke and fenugreek extracts. The method is 
based on the scavenging of DPPH radical through the action of an antioxidant that 
decolourizes the DPPH solution. The procedure was described by Molyneux (2004) [5]. 
200 µl of extract were added to 300 µl of methanol and 2400 µl DPPH solution (22.6 
µg/ml). The mixture was left to stand at room temperature for 30 minutes in the dark and 
filtered (0.45 µm) before the absorbance was measured at 517 nm. (UV/VIS 
Spectrometer, Perkin Elmer Lambda 35). All the measurements were performed in 
triplicate. The results were expressed as ascorbic acid equivalents by means of the dose-
response calibration curve. The sample concentration providing 50 % inhibition (IC50) 
was calculated from the graph of inhibition percentage against sample concentration. 
Each extract was measured in triplicate. 
2.4. Drosophila melanogaster based tests 
2.4.1. Methods to study viability of Drosophila melanogaster 
To collect fertilized eggs, 50 females and males were placed in egg collection cages 
that were put on egg collecting media containing agar, active carbon and yeast paste. Flies 
were kept at 25°C and left overnight to lay eggs that were collected every morning and 
batches of 50 embryos were put on normal media containing vials. Such vials were placed 
in 25°C incubator and supplemented at different time point with different amount of crude 
and alcoholic artichoke or fenugreek extracts. Later the hatched adults were scored, and 
the viability expressed as the % of treated embryos/hatched adults. 
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2.4.2.SMART (Somatic Mutation and Recombination Test) method 
Drosophila melanogaster is a suitable organism to study the mutagenic effect of 
physical, chemical and biological mutagens. Several mutagenic tests were developed to 
study such events in both somatic and germ line cells. One such a method is called 
SMART (somatic mutation and recombination test), and is suitable to detect both 
chromosomal breaks and gene type of mutations induced during larval wing disc 
development by assessing the adults wings (Figure 1). 
Initially, at the beginning of larval development the wing disc is composed of 10-12 cells 
that will divide mitotically and grow during the successive larval stages by performing 
normal cell cycles lasting at about 10 hours (see Fig.10). Therefore, the number of cells 
inside the wing disc will increase exponentially reaching finally at about 50.000 cells. At 
the end of larval development, these cells will cease their mitotic divisions, and after 
pupariation, the wing disc will get transformed into the adult wing that is composed of 
about 30.000 epithelial cells. In normal conditions, as a result of adult wing 
differentiation, every wing cell will feature a hair. In Drosophila m. there have been 
described mutations that can affect the wing hair phenotype like multiple wing hair – mwh 
with several short bristles and flair -flr leading to one shorter than normal and hook like 
hair structure. Crossing together mwh,+/mwh,+ females to males with +, flr/TM2,+,+ 
genotype will produce two kind of genotypic individuals in the first generation (see  
Figure 1. SMART system. Chromosomes depicted in black and blue are representing the 
3rd homologous pair, yellow regions along the black balancer chromosome are indicating 
multiple inversions. The (+) signs correspond to the wild-type allel of mwh or flr gene, 
respectively. 
Taking in consideration that all mutations arise from a single cell, Szabad et al. (1983) 
suggested that the frequency (f) of chromosomal (mitotic recombination) mutations can 
be estimated as f=((n x m))/((N x C)) , where m is the mean size of the clone (cell number), 
n is the number of clones, N is the number of scored wings,  and C is the number of cells 
in the adult wing (30,000 wing blade cells). In order to determine the frequency (f) of 
mwh gene specific mutations, the above mentioned formula has to be modified as =
(𝟐𝒏 𝒙 𝒎)
(𝑵 𝒙 𝑪)
 ,  where m is the mean size of the clone (cell number), 2n is the number of 
mwh/mwh clones, N is the number of scored wings, and C is the number of cells in the 
adult wing (30,000 wing blade cells). 
Virgin females of mwh/mwh were mated to flr3/In (3LR) TM2, Ubx males. Eggs from such 
cross were collected at 25 °C and 60%–80% humidity, in the dark, for 4 h in egg cages 
   
mwh flr + + 
   
mwh + + balancer   
    
 
mwh 
flr 
+ 
+ 
mwh 
+ balancer 
Parents 
F 1 generation 
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placed on egg collecting media supplemented with baker’s yeast. Embryos were removed 
from the egg collecting media and placed on normal media containing vials. Three days 
later, the larvae (72 ± 4 h) were washed out of the vials with tap water through a meshed 
stainless steel strainer. These larvae were transferred to vials containing 1.5 g of dry 
Drosophila Instant Medium (Carolina Biological Supply, Burlington, NC, USA) 
rehydrated with 5 mL of the test solutions containing different amounts of tested artichoke 
or fenugreek extracts. The larvae were allowed to feed on these media until pupation. 
Approximately 10 to 12 days after treatment, the emerging flies were collected, and 
separated into two phenotypic classes based on the presence or absence of TM2, Ubx 
balancer chromosome. After phenotypic classification the flies were stored separately in 
a solution containing 2 part of 70% ethanol and 1 part of glycerol. Wings of flies of both 
sexes from the two phenotypic classes were mounted on slides using Faure’s solution (30 
g gum Arabic, 20 mL glycerol, 50 g chloral hydrate, 50 mL water) and searched 
microscopically for mwh/mwh and flr3/fl3 single or twin wing spot phenotypes. Because 
of the weak expression of the flr3 marker in small clones and its lethality in large clones 
of mutant cells, only the mwh/mwh clones were used to calculate clone formation 
frequencies as we have already described in previous chapter. The frequency of each type 
of spot (small single, large single or twin) and the total frequency of spots per wing for 
each fenugreek extract were compared pair-wise with the frequency of negative 
concurrent controls (normal media). 
2.5. Human cell lines based in vitro tests 
2.5.1. Cell lines 
The two types of human, adherent breast cancer cell lines (T-47D and ZR-75-1) 
were obtained from ATCC (American Type Culture Colection, USA). At normal 
culturing conditions the cell cycle lasts for 32 hr in case of T-47D, while the ZR-75-1 
cells doubling time is 80 hr. 
2.5.2. Cell culturing conditions 
These ductal carcinoma cell lines were grown in T25 or T75 flasks (Greiner Bio-
One Gmbh) in RPMI-1640 (Lonza) culture medium supplemented with 1% Antibiotic 
Antimycotic Solution (Invitrogen-Gibco), 10% heat-inactivated FBS (Fetal Bovine 
Serum; Sigma) and 0,1% 1 mM Na-pyruvate (Biochromag). All cell culture experiments 
were carried out at 37°C in 5% CO2 incubator. 
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2.5.3. MTT viability/proliferation test 
Cells were used in this studies when 80% confluence was reached in T75 flasks 
(Greiner Bio-One GmbH). Cells were washed twice with sterile PBS, and harvested with 
Trypsin in the incubator. For counting the cells we used Trypan blue dye (Sigma) 
exclusion method and counted with Bürker chamber. After it the cells were seeded into 
96-well plates at a density of 104 cells/well and left to attach to the plates. After 24 hours 
cells were incubated for two and three days with various concentrations (10-5-2.5-1.25-
0.62-0.31-0.16-0.08-0.04 v/v%) of extracts. After the exposure time removed the extracts 
and the cells were incubated with ten microliter of MTT (5 mg/ml) (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (Sigma) at 37°C for three hours. 
After dissolving the formazan crystals in MTT solubilization solution, plates were read 
in a microplate reader (BioTek EL808) at 570 nm. This experiment was performed in 
sextuplicates and repeated three times (Mosmann, 1983). 
2.5.4. Immunostaining 
The treatments with both fenugreek extracts were carried out in six-well plates and 
at the examined concentration range. At the bottom of each well, a coverslip was laid and 
cells were let to grow on the surface of coverslip.  After 2- and 3-day treatments the cells 
were fixed with formaldehyde and stained as described by Mathe et al. (2004) and Lemos 
et al. (2000). The microtubules were detected with YL1/2 rat monoclonal anti-α-tubulin 
antibody (Sera Lab, Inc.), and POLO like kinase-1 (Plk1) was stained with mouse 
monoclonal Anti-hPlk1 antibody (P5998 Sigma-Aldrich), while the DNA was 
counterstained with the DAPI dye (Molecular Probes). Digital images of optical sections 
were collected with an Olympus Cell R inverted fluorescent microscope system equipped 
with a Hamamatsu CCD camera controlled by the Olympus XcellenceR imaging 
software, using a Plapon 60x objective.  
2.6. Statistical analysis 
Statistical analysis were performed by the SPSS 16.0 software. Statistical 
differences among treated and untreated cells were determined by one-way ANOVA 
(Analysis of Variance). To compare several groups was applied the Tukey post-hoc test, 
and mean differences with p< 0.05 were considered statistically significant. 
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3. MAIN OBSERVATIONS AND RESULTS OF DISSERTATION 
3.1. Characterization of bioactive compound profile of different of artichoke and 
fenugreek extracts by UHPLC-ESI-MS system 
Our study was meant to identify all possible bioactive compounds with the applied 
UHPLC-ESI-MS system, and as a consequence 49 and 51 molecules were found in the 
aqueous and hydro-alcoholic artichoke extracts, respectively (Figure 2-5). 
 
Figure 2. Total ion chromatogram of aqueous extract of Artichoke in positive ionisation 
mode. 
 
Figure 3. Total ion chromatogram of aqueous extract of artichoke in negative ionisation 
mode. 
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Figure 4. Total ion chromatogram of hydro-alcoholic extract of artichoke in positive 
ionisation mode. 
 
Figure 5. Total ion chromatogram of hydro-alcoholic extract of artichoke in negative 
ionisation mode. 
There have been 54 bioactive compounds identified in the aqueous fenugreek seed 
extract, while in case of hydro-alcoholic extract 67 molecules were found as shown on 
coresponding chromatograms (Figure 6-9). 
 
Figure 6. Total ion chromatogram of aqueous extract of fenugreek in positive ionisation 
mode. 
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Figure 7. Total ion chromatogram of aqueous extract of fenugreek in negative ionisation 
mode. 
 
Figure 8. Total ion chromatogram of hydro-alcoholic extract of fenugreek in positive 
ionisation mode. 
 
Figure 9. Total ion chromatogram of hydro-alcoholic extract of fenugreek in negative 
ionisation mode. 
The phytoconstituents were defined based on specific retention time, accurate mass, 
isotopic distribution and fragmentation pattern, and by screening MS databases like 
Metlin, mzCloud and Massbank. The UHPLC-ESI-MS analysis of artichoke and 
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fenugreek extracts revealed similarities and differencies regarding their bioactive 
compound profile. In Table 1. are indicated the numbers of identified compounds specific 
for the studied bioactive compound cathegory. 
Table 1. Number of bioactive compounds identified in the aqueous and alcoholic 
artichoke and fenugreek extracts 
Bioactive 
compound 
category  
Aqueous 
artichoke 
Hydro-
alcoholic 
artichoke 
Aqueous 
fenugreek 
Hydro-
alcoholic 
fenugreek 
Alkaloids 3 2 4 4 
Aminoacids 7 9 12 11 
Coumarins 2 3 - 1 
Flavonoids 7 13 7 16 
Other 
metabolites 
3 4 3 3 
Polyphenols 9 3 1 2 
Purines and 
pirimidines 
9 6 10 9 
Saponins 2 2 14 16 
Terpenoids 1 2 - 1 
Steroids - 2 - - 
Vitamines 5 4 3 4 
Total 48 50 54 67 
It is important to notice that the preparation methods for the aqueous and hydro-alcoholic 
extracts were identical for artichoke and fenugreek. Moreover, the same UHPLC-ESI-
MS method was applied for the analysis of the extracts, and therefore the obtained results 
are directly comparable. 
In case of artichoke the described bioactive compound profile strongly supports the liver 
and gallbladder tonic effect of artichoke by interfering with lipid metabolism. Moreover, 
some kind of anti-cancerous effect could also be expected based on some 
phytoconstituents. Based on individual effects of the identified phytoconstituents, 
multiple mechanisms could be evoked to explain the artichoke health promoting effects 
like the inhibition of cholesterol synthesis and lipolysis, together with the activation of 
anti-inflammatory, anti-tumour growth cellular pathways. 
The comparative chemomapping of aqueous and hydro-alcoholic fenugreek seed extracts 
revealed already known and new bioactive compounds that further support the 
antidiabetic effects of fenugreek seeds. The presence of some bioactive compounds in our 
extracts is expected to improve blood lipid spectre (4-OH-Ile, diosgenin), and to show 
13 
 
reno-protective (4-OH-Ile, trigonelline), neuroprotective (trigonelline) and antioxidant 
(diosgenin, trigonelline) properties. Other phytoconstituents identified in our seed 
extracts plead for a more substantial neuroprotective (kynurenine, genistein, vitexin, 
isovitexian), anti-inflammatory (trigonelline, scopoletin, ursolic acid, vitamins), 
hypocholesterolemic (saponins), muscle and/or hepatic insulin resistance reducing 
(choline) effects. 
3.2. Comparative quantitative analysis of some bioactive compounds from artichoke 
and fenugreek extracts and their associated antioxidant capacity 
 
Figure 10. Spectrophotometric methods: Note: (AC) antioxidant capacity, (TF) total 
flavonoid, (TP) total phenolic, (AqA) aqueous artichoke extract, (AlA) alcoholic 
artichoke extract, (AqF) aqueous fenugreek extract, (AlF) alcoholic fenugreek extract 
From the obtained data we can conclude that the aqueous artichoke and fenugreek 
extracts antioxidant capacities were relatively high, while the alcoholic artichoke and 
fenugreek extracts antioxidant capacities were markedly reduced as compared to their 
corresponding aqueous counterparts. The aqueous extract compared to the hydro-
alcoholic extract showed an approximately 16 times greater antioxidant capacity in case 
of artichoke. In case of fenugreek the aqueous extract showed a 5 time greater antioxidant 
capacity than the hydro-alcoholic extract (Figure 10). 
The total flavonoid content of artichoke and fenugreek hydro-alcoholic extracts exceeded 
substantially the flavonoid content seen in both plants derived aqueous extracts. 
Accordingly, the artichoke specific hydro-alcoholic extract total flavonoid content 
appears 3 times greater as compared to the aqueous extract. The fenugreek total flavonoid 
content of the hydro-alcoholic extracts looks almost 12 times greater than the aqueous 
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extract related values. Moreover, if the two plants specific hydro-alcoholic extracts are 
compared, it looks obvious that the fenugreek values are two times greater than the 
artichoke values for total flavonoid content suggesting that the fenugreek seeds contain 
twice as much flavonoid than the artichoke. Surprisingly, when the aqueous extracts of 
artichoke and fenugreek are compared, the artichoke extract specific total flavonoid 
content was approximately double to that seen in case of fenugreek extract. 
The total phenolic content of artichoke hydro-alcoholic extract exceeded more than 2 
times the values observed for the artichoke aqueous extract suggesting that the hydro-
alcoholic artichoke extract contains twice as many phenolic compounds like the aqueous 
artichoke extract. However, the aqueous and hydro-alcoholic fenugreek extracts seemed 
to contain similar amount of phenolic compounds. Surprisingly we were unable to detect 
anthocyanin in any of our artichoke and fenugreek extracts (Figure 10). 
3.3. In vivo analysis of artichoke and fenugreek extracts effects using Drosophila 
melanogaster 
3.3.1. Analysis of artihoke and fenugreek extracts effects on the viability of fruitflies 
In order to assess the putative toxic effect of our fenugreek extracts we set to study 
the way they could affect the viability of treated fruit flies. F1 embryos from two crosses 
were collected, while their pupariation and adult hatching were monitored on normal 
media and media containing undiluted or diluted (10-1, 10-2) artichoke or fenugreek 
aqueous or hydro-alcoholic extracts. The obtained data are summarized in Tables 2-3. 
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Table 2. Viability assessment of untreated and artichoke extracts treated flies. Control 
experiments specific data are marked with yellow. Green color refers to aqueous 
artichoke extract, while blue color represents the hydro-alcoholic artichoke extract 
experiments. The viability rate refers to the hatched adults as compared to the extract 
treated embryos. Control-NM indicates the normal media, while Control-DIM refers to 
the instant media. 
 
Parents 
crossing 
Treatment 
Ʃ F1 
treated  
embryo  
F1 
larva 
Hatched 
F1 
imago 
F1 
viability 
rate 
(%) 
Average F1 
viability 
rate 
(%) 
 
 
 
 
 
 
♀wm4h 
x 
♂wm4h 
Control-NM 1000 972 956 95.6 
Control-DIM 1000 988 952 95.2 
Aqueous 
artichoke 
stock solution 
1000 968 962 96.2  
 
 
 
95.2 
Aqueous 
artichoke 
1:10 dilution 
1000 957 952 95.2 
Aqueous 
artichoke 
1:100 dilution 
1000 972 944 94.4 
Hydro-
alcoholic 
artichoke  
stock solution 
1000 958 949 94.9  
 
 
 
93.8 Hydro-
alcoholic 
artichoke  
1:10 dilution 
1000 977 932 93.2 
Hydro-
alcoholic 
artichoke  
1:100 dilution 
1000 968 936 93.4 
 
 
 
♀mwh/mwh 
x 
♂ flr3/TM2, 
Ubx 
Control-NM 1000 984 961 96.1 
Control-DIM 1000 982 966 96.6 
Aqueous 
artichoke 
stock solution 
1000 966 951 95.1  
 
 
 
95.9 
Aqueous 
artichoke 
1:10 dilution 
1000 982 964 96.4 
Aqueous 
artichoke 
1:100 dilution 
1000 975 963 96.3 
H.-alcoholic 
artichoke 
stock solution 
1000 977 943 94.3  
 
 
 
95.1 
H.-alcoholic 
artichoke 
1:10 dilution 
1000 988 95 96.5 
H.-alcoholic 
artichoke 
1:100 dilution 
1000 968 945 94.5 
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Table 3. Viability assessment of untreated and fenugreek extracts treated flies. Control 
experiments specific data are marked with yellow. Green color refers to aqueous 
fenugreek extract, while blue color represents the hydro-alcoholic fenugreek extract 
experiments. The viability rate refers to the hatched adults as compared to the extract 
treated embryos. Control-NM indicates the normal media, while Control-DIM refers to 
the instant media.  
 
Parents 
crossing 
Treatment 
Ʃ F1 
treated  
embryo  
F1 
larva 
Hatched 
F1 
imago 
F1 viability 
rate 
(%) 
Average F1 
viability 
rate 
(%) 
 
 
 
 
 
 
♀wm4h 
x 
♂wm4h 
Control NM 1000 968 956 95.6 
Control DIM 1000 972 944 94.4 
Aqueous 
fenugreek 
stock solution 
1000 946 938 93.8  
 
94.5 
Aqueous 
fenugreek 
1:10 dilution 
1000 953 942 94.2 
Aqueous 
fenugreek 
1:100 dilution 
1000 972 957 95.7 
Hydro-
alcoholic 
fenugreek 
stock solution 
1000 948 926 92.6  
 
93.3 
Hydro-
alcoholic 
fenugreek 
1:10 dilution 
1000 966 947 9.7 
Hydro-
alcoholic 
fenugreek 
1:100 dilution 
1000 952 928 92.8 
 
 
 
♀mwh/mwh 
x 
♂ flr3/TM2, 
Ubx 
Control NM 1000 938 912 91.2 
Control DIM 1000 942 921 92.1 
Aquaous 
fenugreek 
stock solution 
1000 947 922 92.2  
 
92.6 
Aquaous  
fenugreek  
1:10 dilution 
1000 966 941 94.1 
Aqueous 
fenugreek 
1:100 dilution 
1000 933 916 91.6 
H.-alcoholic 
fenugreek 
stock solution 
1000 955 932 93.2  
 
91.9 
H.-alcoholic 
fenugreek 
1:10 dilution 
1000 934 917 91.7 
H.-alcoholic 
fenugreek 
1:100 dilution 
1000 943 921 92.1 
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The average F1 hatching rate was above 91% for both crosses, and the hatching rate 
of aqueous or hydro-alcoholic artichoke and fenugreek extract treated flies were similar 
to the controls, suggesting that the applied artichoke and fenugreek undiluted and diluted 
extracts do not exert toxic effects on Drosophila melanogaster. 
3.3.2. Artihoke and fenugreek extracts assessed for their genotoxic effect using the 
SMART method 
Having seen that neither the aqueous nor the hydro-alcoholic artichoke and 
fenugreek extracts are affecting the viability of F1 individuals, we treated the F1 larvae 
from the ♀mwh/mwh x ♂ flr3/TM2, Ubx cross with undiluted extracts to perform the 
wing specific SMART assay. Among the F1 progeny, the wings of mwh, +/+, flr3 
transheterozygous flies were analysed for mosaic clones, and the corresponding data are 
shown in Table 4. 
Table 4. Frequency of clone induction in case of mwh, +/+, flr transheterozygous flies 
wings. Control experiments specific data are marked with yellow. Green colors refer to 
fenugreek extracts, while brown color indicates the fenugreek extracts based experiments. 
 
Treatment 
 
Wing 
 
(N) 
Mosaic clone  
Frequen
cy of 
clones 
 
(n/N) 
Mean 
cell no./ 
clone 
(m) 
Frequency 
of clone 
induction 
(f=nm/NC) 
 
twin 
single Total 
clone 
number 
(n) 
mwh flr 
Control 107 3 55 1 59 0.55 1.1±0.2 2.0 x 10-5 
Aqueous 
artichoke 
98 5 51 - 56 0.57 1.2±0.4 2.3 x 10-5 
Hydro-
alcoholic 
artichoke 
106 4 53 1 58 0.55 1.1±0.4 2.0 x 10-5 
Aqueous 
fenugreek 
135 5 53 3 61 0.49 1.6±0.4 2.4 x 10-5 
Hydro-
alcoholic 
fenugreek 
142 6 54 5 65 0.46 1.4±0.6 2.1 x 10-5 
Looking at the frequency of clones, mean cell number/clone and the frequency of 
clone induction there were no obvious differences between the untreated control and 
crude or alcoholic fenugreek extract treated mwh, +/+, flr transheterozygous individuals. 
These data are indicating that the crude or alcoholic fenugreek extracts are not inducing 
chromosomal breaks (mitotic recombination) at a higher extent than those seen in case of 
control untreated individuals.  
Among the F1 progeny, the wings of mwh/ TM2, Ubx transheterozygous flies were 
analyzed for mosaic clones, and the corresponding data are shown in Table 5.  
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Table 5. Frequency of clone induction in case of mwh/Balancer flies wings. Control 
experiments specific data are marked with yellow. Green colors refer to fenugreek 
extracts, while brown color indicates the fenugreek extracts based experiments. 
Treatment 
 
Wing 
 
 
(N) 
Total 
mwh 
clone 
number 
(n) 
Frequency 
of clones 
 
(n/N) 
Mean cell 
no./clone 
  
(m) 
Frequency of 
clone induction 
 
(f=2nm/NC) 
Control 106 11 0.1 2.4 ± 1.6 1.6 x 10-5 
Aqueous 
artichoke 
114 12 0.1 2.2 ± 1.2 1.5 x 10-5 
Hydro-
alcoholic 
artichoke 
102 11 0.1 2.4 ± 1.4 1.7 x 10-5 
Aqueous 
fenugreek 
112 12 0.11 2.4 ± 0.8 1.7 x 10-5 
Hydro- 
alcoholic 
fenugreek 
116 14 0.12 2.2 ± 0.6 1.8 x 10-5 
Looking at the frequency of clones, mean cell number/clone and the frequency of 
clone induction there were no obvious differences between the untreated control and 
crude or alcoholic fenugreek extract treated mwh/TM2, Ubx individuals. These data are 
indicating that the crude or alcoholic fenugreek extracts are not inducing mutations in the 
mwh locus situated on the TM2 balancer chromosome at a higher extent than those seen 
in case of control untreated individuals. 
The toxicity and mutagenic effect of aqueous and hydro-alcoholic artichoke and 
fenugreek extracts when tested on Drosophila melanogaster revealed no viability 
reducing effect or increased mutational (gene and chromosomal breaks) rata, suggesting 
that both extracts are suitable for studying their mechanisms of action with respect to the 
contained bioactive compounds. 
3.4. Artichoke and fenugreek extracts in vitro testing on human breast cancer cell 
lines 
The T-47D and ZR-75-1 human breast cancer cell lines were treated for 2 to 3 days 
at a wide concentration spectra of different aqueous and hydro-alcoholic artichoke and 
fenugreek extracts, respectively. For every applied extract concentration using the MTT 
test, the viability of treated breast cancer cells was determined. In the following I will 
present only the 3-day treatment specific data (Figure 11-16). 
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Figure 11. Cell viability after 3-day treatment using aqueous artichoke extract. The T-
47D cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
Looking at the 3-day treatment experiments of T-47D breast cancer cells, in the 10-
0.63% concentration range of aqueous artichoke extract, the viability of treated cancerous 
cells was 5 times reduced, yet constant, throughout the assessed concentration values as 
compared to control untreated cells. It seems likely that the 0.31% concentration could 
be close to the LD50 value in this experiment. Started from the 0.16% concentration point, 
and ended with the 0.04% concentration of artichoke leaf extract, the viability of treated 
cells was increasing progressively. At 0.08% and 0.04% extract concentrations, the 
viability of treated cells surpassed approximately 1.5 times the values of untreated control 
cells (Figure 11). 
Looking at the 3-day treatment experiments of ZR-75-1 breast cancer cells, in the 
10-0.31% concentration range of aqueous artichoke extract, the viability of treated 
cancerous cells was markedly reduced, yet constant, throughout the assessed 
concentrations at about 8.5 times lower viability was detected as compared to control 
untreated cells. The 0.16% concentration could be considered the LD50 value in this 
experiment. In the 0.08-0.04% concentration range of artichoke extract, the viability of 
treated cells was increasing progressively. At 0.04% extract concentration, the viability 
of treated cells surpassed 1.2 times the untreated control cells specific values (Figure 12).  
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Figure 12.  Cell viability after 3-day treatment using aqueous artichoke extract. The ZR-
75-1 cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
 
 
Figure 13. Cell viability after 3-day treatment using aqueous fenugreek extract. The T-
47D cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
Looking at the 3-day treatments of T-47D breast cancer cells, in the 10-0.31% 
concentration range of aqueous fenugreek extract, the viability of treated cancerous cells 
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was 8 times lower, yet constant, throughout the assessed concentration range as compared 
to control untreated cells. The 0.16% concentration seems to be close to the hypothetical 
LD50 value in this experiment. Across the 0.16-0.04% concentration range, the viability 
of treated cells was steadily increasing. At 0.08% extract concentrations, the viability of 
treated cells equaled those specific to the control cells, while at 0.04% extract 
concentration the viability of cells surpassed showed a 1.2 fold increase as compared to 
the values of untreated control cells (Figure 13). 
 
Figure 14.  Cell viability after 3-day treatment using aqueous fenugreek extract. The ZR-
75-1 cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
Looking at the 3-day long treatments of ZR-75-1 breast cancer cells, at the 10-
0.63% concentration interval, the viability of treated cancerous cells was markedly 
reduced, and constant, showing at about 8 times lower values as compared to control 
untreated cells. The LD50 value is expected to fit in between 0.31-0.16% concentration 
interval in this experiment. In the 0.31-0.04% concentration range, the viability of treated 
cells was increasing progressively. At 0.08% extract concentration, the viability of treated 
cells was similar to the untreated control cells. However, at 0.04% extract concentration, 
the viability of treated cells surpassed 1.2x the values observed for untreated control cells 
(Figure 14). 
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Figure 15. Cell viability after 3-day treatment using hydro-alcoholic artichoke extract. 
The T-47D cell viability was measured by MTT assay. C-stands for untreated or positive 
control cells. MTT- represents the negative control. 
At the 3-day treatment experiments of T-47D breast cancer cells, I could observe in the 
10-0.08% concentration range that the viability was greatly reduced for treated cancerous 
cells. Throughout the above mentioned concentration range the low viability values show 
some degree of variation. Accordingly, in the 10-0.63% concentration range the viability 
of treated cells was approximately 9 times lower as compared to control cells. In the 0.31-
0.08% concentration rage, the viability of treated cells increased, yet compared to controls 
was approximately 5.5 times lower. Nevertheless, in the case of the applied lowest 0.04% 
concentration, the viability of treated cells increased but, did not reach 50%, suggesting 
that this working concentration does not corresponds to a LD50 value (Figure 15). 
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Figure 16. Cell viability after 3-day treatment using hydro-alcoholic artichoke extract. 
The ZR-75-1 cell viability was measured by MTT assay. C-stands for untreated or 
positive control cells. MTT- represents the negative control. 
At the 3-day treatment experiments of ZR-75-1 breast cancer cells, I could observe 
throughout the analyzed concentration range that the viability was greatly reduced for 
treated cancerous cells. The observed viability values showed some minor variation 
throughout the monitored concentrations but did not differ significantly from each other. 
The viability of treated cells was approximately 13 times lower as compared to control 
cells. All the observed viability values were far from reaching the expected LD50 value 
(Figure 16). 
Having seen the above described viability reducing effects in the case of our artichoke 
leaf extracts treated cells we set to analyze the cells phenotype by assessing their 
chromosomal structure. Among the artichoke leaf extract treated cells we were able to 
detect some normal interphase and mitotic cells, but there were also polyploidy cells, 
binuclear cells, and cells showing minispindle and sometime multipolar spindle (Figure 
17). The polyploidy cells quite often were showing overcondensed and/or fragmented 
chromosomes features that are specific to cells entering senescence and/or apoptosis. 
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Figure 17. Immunostainigs of artichoke extract treated breast cancer cells.  
Note. A. Normal looking cells in interphase, at mitotic metaphase (arrow) and binucleated 
cell (star); green indicates microtubules, blue stands for DNA. B-C. Polyploidy cell with 
fragmented chromosomes and/or micronuclei (arrowhead). Minipindle with 
overcondensed chromosomes (arrow). Binucleated cell (star); green indicates 
microtubules, blue stands for DNA. 
 
At the 3-day treatment experiments of T-47D breast cancer cells, I could observe that the 
viability was greatly reduced for treated cancerous cells at all concentration assessed 
(Figure 18). The observed significantly low viability values showed some but minor 
degree of variation. Accordingly, the viability of treated cells was approximately 8-16 
times lower as compared to control cells. It is also evident that the 3-day long applied 
alcoholic fenugreek extract concentrations are featuring a great level of toxicity. 
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Figure 18. Cell viability after 3-day treatment using alcoholic fenugreek extract. The T-
47D cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
 
Figure 19. Cell viability after 3-day treatment using alcoholic fenugreek extract. The ZR-
75-1 cell viability was measured by MTT assay. C-stands for untreated or positive control 
cells. MTT- represents the negative control. 
At the 3-day treatment experiments of ZR-75-1 breast cancer cells, I could observe 
throughout the analyzed concentration interval that the viability was even more 
pronouncedly reduced in case of treated cancerous cells. The viability of treated cells was 
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approximately 20 times lower as compared to control cells in the concentration interval 
10-0.63%. Next, in the concentration interval 0.31-0.04%, the viability of treated cells 
was about 9 times lower than in case of control untreated cells. All the observed viability 
values were very far from the expected LD50 value (Figure 19). 
In order to find out how these extracts are influencing the treated cells we set to 
analyze by immunostaining their phenotype, hoping that the identified defects would 
reveal details regarding the affected cellular phenomena. Such an approach would 
correspond to a phenotypic study, but contrary to a classical genetic analysis where 
mutant alleles generated phenotypes are described, in our experiments the extracts are 
responsible for the impeded biological phenomenon. Both fenugreek seed extracts are 
affecting the viability of the analyzed cancerous cell lines in a dose dependent fashion, 
and by immunostaining we were able to detect multiple cellular defects. We could 
identify cell division defects and apoptosis like characteristics. Therefore, we were able 
to detect normal looking interphase and dividing cells, together with multi-nucleated 
presumably aneuploid cells, other cells with small or multi-polar spindles, and cells 
showing nuclear blobbing or fragmented chromosomes, the latter being specific to 
apoptosis (Figure 20-21). We also looked at the structure of mitotic spindles, and by 
monitoring the Polo like kinase-1 (Plk1) subcellular localization we taught to gain more 
information about mitotic entry, spindle assembly, chromosome alignment, sister 
chromatid segregation, metaphase-anaphase transition and cytokinesis. It has been 
demonstrated that Plk1 regulates almost every aspect of mitotic events, and its 
overexpression is a marker for poor prognosis in many cancers (Weng et al., 2016). In 
the case of fenugreek extracts treated cells we were able to found that Plk–1 in some 
instances is associated with centrosomes, while in others shows some accumulation along 
the central spindle microtubules of the spindle apparatus (Figure 20). 
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Figure 20. Immunostaining of fenugreek extract treated cancer cells. 
Note. A. Untreated cells in interphase together with giant nuclei cells (star) and normal 
anaphase (arrow). B. Untreated cells at interphase (arrowhead) and mitotic metaphase 
(arrow). C. Extract treated cell with abnormal multipolar spindle showing accumulation 
of chromosomes at spindle poles (arrowhead). D. Extract treated cell showing nuclear 
blobbing and abnormal microtubule network (arrow) as compared to a normal interphase 
cell (plus).Green indicates microtubules and blue shows the chromosome specific DNA. 
The scale bar represents 20μm. 
 
Despite the fact that the performed immunostaining revealed certain cellular defects 
presumably generated by the fenugreek extract based treatments, we did not carry out a 
quantitative analysis since after 2- and 3-day treatments usually the cell number was 
greatly reduced. To gain a much clearer picture it will be necessary to carefully assess the 
phenotypes all treated cells by FACS (Fluorescence-activated cell sorting) analyses. 
 
 
A B 
C D 
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Figure 21. Immunostaining of fenugreek extract treated cancer cells. Note. A. Normal 
cells in interphase (star) and cytokinesis (arrow). B. cell at mitotic metaphase-anaphase 
transition with centrosomes at spindle poles and PLK associated with centrosomes but 
not kinetochores (arrow). C. Extract treated cell with abnormal bipolar spindle showing 
normal centrosome at one pole with Plk-1 accumulation (arrow), while the opposite pole 
is much broader with no centrosome (arrowhead) and some PLK accumulation along the 
spindle microtubules (plus). D. Extract treated cell with abnormal monopolar spindle 
showing PLK accumulation at the spindle pole associated centrosome (arrow). Green 
indicates microtubules, red stands for Plk, and blue shows the chromosome specific DNA. 
The scale bar represents 20μm. 
 
 
 
 
 
 
 
 
 
 
 
D C 
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4. NEW SCIENTIFIC RESULTS OF THE DISSERTATION 
1. In the dried artichoke leaves made aqueous and hydro-alcoholic extracts I have 
identified 49 and 51 bioactive compounds, respectively. Among them, 27 
bioactive compounds have been for the first time shown to be present in artichoke. 
These newly identified bioactive compoundsa are the following:  kynurenic acid, 
trigonelline, stachydrine (alkaloids); 4-Guanidinobutyric acid, arginine, 
tryptophan, N-Acetyl-isoleucine, N-Acetil-leucin (aminoacids); esculin, 5-O-
Caffeoylshikimic acid I, 5-O-Caffeoylshikimic acid II, Coumaroylquinic acid I, 
Coumaroylquinic acid II (polyphenols); diosmetin, salvigenin, naringin-dihydro-
chalcone, vicenin-2 (flavonoids); 7-Methoxy-4-methyilcoumarin (coumarin); 
choline, methyl cinnamate, phenethylamine (other metabolites); ursolic acid 
(terpenoid); stearidonic acid methyl ester, stearidonic acid ethyl ester (steroids); 
pantothenic acid (B5), pyridoxal, pyridoxine (B6) (vitamines). 
2. Using the Hungarian fenugreek seeds I was able to identify 54 compounds in the 
aqueous extract, while in the hydro-alcoholic extract 67 molecules were 
identified. All together in the two extracts 25 new bioactive compounds were 
found like ecgonine, ecgonine methyl ester (alkaloids); resveratrol (polyphenol); 
tricin-7-O-glucoside, genistein, isovitexin (apigenin-6-C-glucoside), medicarpin, 
scoparin, apigenin-6-C-glucoside-8-C-rhamnoside (flavonoids); sotolone, 
saccharopine (other metabolites); 5’-S-Methyl-5’-thioadenosine, 2’-
deoxyadenosine, adenine, adenosine, adenosine 3’,5’-cyclic-monophosphate 
(cAMP), cytidine, flavin mononucleotide (FMN), guanine, guanosine, S-
adenosyl-homocysteine, uridine, xanthine (purines and pyrimidines); ursolic acid 
(terpenoid); nicotinamide (vitamine). 
3. The aqueous artichoke and fenugreek extracts tested on T-47D and ZR-75-1 
human breast cancerous cell lines are featuring a hormetic type of response with 
biphasic effect.  
4. The hydro-alcoholic artichoke and fenugreek extracts are cytotoxic and induce 
apoptosis on T-47D and ZR-75-1 human breast cancerous cell lines at a very wide 
concentration spectra.  
5. The Drosophila melanogaster  based experiments are indicating that any of the 
tested artichoke or fenugreek extracts do not affect the viability of fruitflies. 
Moreover, any of the extracts did not increased the gene and chromosomal 
mutational rate as revealed by the SMART method, so that they are not genotoxic. 
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5. PRACTICAL UTILIZATION OF THE SCIENTIFIC RESULTS 
Based on all my results presented in my dissertation it seems likely that the 
artichoke and fenugreek aqueous and hydro-alcoholic extracts might be suitable after 
careful assesments for the development of nutraceuticals or functional foods to prevent 
breast cancer or to use as complementary treatment for breast cancer patients. 
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